Suppr超能文献

IVUS引导下经皮深部足部静脉动脉化治疗无选择的糖尿病严重肢体缺血患者

Percutaneous Deep Foot Vein Arterialization IVUS-Guided in No-Option Critical Limb Ischemia Diabetic Patients.

作者信息

Cangiano Gianluca, Corvino Fabio, Giurazza Francesco, De Feo Eugenio Maria, Fico Francesca, Palumbo Vincenzo, Amodio Francesco, Silvestre Mattia, Corvino Antonio, Niola Raffaella

机构信息

Interventional Radiology Department, 18617AORN "A. Cardarelli," Naples, Italy.

Diabetic Foot Unit, Department of General and Specialist Medicine, 18617AORN "A. Cardarelli," Naples, Italy.

出版信息

Vasc Endovascular Surg. 2021 Jan;55(1):58-63. doi: 10.1177/1538574420965743. Epub 2020 Oct 14.

Abstract

PURPOSE

To report our clinical experience with IVUS-guided percutaneous deep vein arterialization (pDVA) to treat chronic critical limb ischemia (cCLI) patients with no-endovascular or surgical options approach due to creation of an arteriovenous fistula (AVF).

MATERIALS AND METHODS

In a 2 years period, 14 no-option cCLI patients were treated with percutaneous deep vein arterialization (pDVA) by creating an AVF with a IVUS-guided system between posterior tibial artery and its satellite deep vein. Technical success was defined as successful AVF creation and venous perfusion of the wound site. Patients' characteristics, procedure details, mortality and wound outcomes were assessed prospectively.

RESULTS

Successful pDVA was successfully performed in all patients (mean age 82 years) without any procedural complications. Clinical improvement was achieved in all patients with resolution of rest pain, tissue formation of granulation tissue or both; only 3 major amputations were performed within the study period with a limb salvage rate of 78%. Median wound healing time was 4.8 months.

CONCLUSION

pDVA is a safe and feasible revascularization technique alternative in no-option cCLI patients.

摘要

目的

报告我们在血管内超声引导下经皮深静脉动脉化(pDVA)治疗因动静脉瘘(AVF)形成而无血管内或手术选择的慢性严重肢体缺血(cCLI)患者的临床经验。

材料与方法

在2年期间,14例无选择的cCLI患者通过血管内超声引导系统在胫后动脉与其伴行的深静脉之间建立动静脉瘘,接受经皮深静脉动脉化(pDVA)治疗。技术成功定义为成功建立动静脉瘘且伤口部位有静脉灌注。前瞻性评估患者特征、手术细节、死亡率和伤口结局。

结果

所有患者(平均年龄82岁)均成功进行了pDVA,无任何手术并发症。所有患者均实现了临床改善,静息痛缓解、肉芽组织形成或两者皆有;研究期间仅进行了3例大截肢手术,保肢率为78%。伤口愈合中位时间为4.8个月。

结论

pDVA是无选择的cCLI患者一种安全可行的血管重建技术选择。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验